Efficacy of the apitherapy in the treatment of recalcitrant localized plaque psoriasis and evaluation of tumor necrosis factor-alpha (TNF-α) serum level: A double-blind randomized clinical trial

References

• Feldman S. Advances in psoriasis treatment. Dermatol Online J. 2000;6:4
   PubMedGoogle Scholar
• Menter MA, Krueger GC, Feldman SR, Weinstein GD. Psoriasis treatment at the new Millenniunm: position paper on behalf of authors. J Am Acad Dermatol. 2003;49:S39–43
   PubMed Web of Science ®Google Scholar
• Woolston C. Bee venom therapy (bee stings). Alternat Med. 2003;9:1424–8
   Google Scholar
• Vanks BEC, Shipolini RA. Chemistry and Pharmacology of Honey–bee Venom in Venoms of Hymenoptera. London: Academic press, 1986
   Google Scholar
• Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011;13:15–20
   Google Scholar
• Won CH, Hong SS, Kim CM-H. Efficacy of apitox (bee venom) for osteoarthritis: a randomized controlled trial. J Am Apitherapy Soc. 2000;7:11–14
   Google Scholar
• Bonifati C, Berardesca E. Clinical outcome measures of psoriasis. Reumatism. 2007;59:64–7
   PubMedGoogle Scholar
• Dawson B, Trapp RG. Basic and Clinical Biostatistic. 4th ed. New York: Mc Graw Hill, 2004
   Google Scholar
• Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;5:273–9
   Web of Science ®Google Scholar
• Hegazi AG, Abd Raboh FA, Ramzy NE, et al. Bee venom and propolis as a new treatment modality in patients with localized plaque. Int Res J Med Med Sci. 2013;1:27–33
   Google Scholar
• Douglas WS, Poulin Y, Decroix J, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (Stockh). 2002;82:131–5
   PubMed Web of Science ®Google Scholar
• Erceg A, Bovenschen HJ, van de Kerkhof PC, Seyger MM. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study. Br J Dermatol. 2006; 155:110–14
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Masud S, Ramamurthi R, et al. Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris. J Am Acad Dermatol. 2003;48:68–75
   PubMed Web of Science ®Google Scholar
• Yamauchi PS, Gindi V, Lowe NJ. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety. Dermatol Clin. 2004;22:449–59
   PubMed Web of Science ®Google Scholar
• Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 1996;58:1485–507
   PubMed Web of Science ®Google Scholar
• Nam KW, Je KH, Lee JH, et al. Inhibition of COX-2activity and proinflammatory cytokines (TNF-α and IL-1β) production by water-soluble fractionated parts from bee (Apis mellifera)venom. Arch Pharm Res. 2003;26:383–8
   PubMed Web of Science ®Google Scholar
• Park HJ, Lee SH, Son DJ, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF κ B through interaction with the P50 subunit. Arthritis Rheum. 2004;50:3504–15
   PubMed Web of Science ®Google Scholar
• Hadjipetrou-Kourounakis L, Yiangou M. Bee venom, adjuvant induced disease and interleukin production. J Rheumatol. 1988;15:1126–8
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman M, Elebiary AS, Hafez SS, et al. Therapeutic activity of bee-stings therapy in rheumatoid arthritis causes inflammation and oxidative stress in female patients. Int J Res Ayureveda Pharm. 2013;4
   Google Scholar
• Krivopalov-Moskvin I, Rozenfeld S, Varnavskaja E, Krivopalov A. Apitherapy in the treatment of multiple sclerosis. Chelyabinsk, Russia: J Apimondia
   Google Scholar
• Janik JE, Wania-Galicia L, Kalauokalani D. Bee stings – a remedy for postherpetic neuralgia? A case report. Reg Anesth Pain Med. 2007;32:533–5
   PubMed Web of Science ®Google Scholar
• Magnan A, Marin V, Mély L, et al. Venom immunotherapy induces monocyte activation. Clin Exp Allery. 2001;3:30–1
   Google Scholar
• Caca-Biljanovska NG, Vlckova-Laskoska MT. Management of guttate and generalized psoriasisvulgaris: prospective randomized study. Croat Med J. 2002;43:707–12
   PubMed Web of Science ®Google Scholar
• Chládek J, Simková M, Vanecková J, et al. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oralmethotrexate during the remission-induction period of treatment for moderate-to-severe plaquepsoriasis. Eur J Clin Pharmacol. 2008;64:347–55
   PubMed Web of Science ®Google Scholar
• Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53:S59–69
   PubMed Web of Science ®Google Scholar